Blood Cancers | Tumor

Light the Night and Survivorship: The Importance of Remembrance

December 14th 2025, 7:00pm

I attended this year’s Light the Night walk in remembrance of my sister, reflecting on her 11-year battle and enduring identity as a cancer survivor.

What Does Minimal Residual Disease Mean?

December 11th 2025, 9:00pm

CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

December 10th 2025, 2:00pm

Emmy-winning journalist and author, Suleika Jaouad, delivered the keynote address at the inaugural Blood Cancer Heroes event.

Insights Into What’s New in Blood Cancer Care

December 8th 2025, 10:00pm

Lore Gruenbaum, chief scientific officer of Blood Cancer United, sat down for an interview with CURE to discuss the themes shaping blood cancer care today.

Xervyteg Shows Strong Responses in Acute Graft-Versus-Host Disease

December 8th 2025, 8:30pm

Xervyteg improved responses and was safe in steroid- and Jakafi-resistant acute graft-versus-host disease affecting the GI tract in a phase 3 trial.

Higher Niktimvo Dosing Feasible in Chronic Graft-Versus-Host Disease

December 7th 2025, 3:19pm

Transitioning treatment with Niktimvo to a dose of 0.6 mg/kg every four weeks appeared feasible for chronic graft-versus-host disease.

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

December 6th 2025, 1:44pm

CURE honored four individuals whose compassion and leadership shaped support education and empowerment for people living with blood cancers.

Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer

October 21st 2025, 3:56pm

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T cell therapy is changing treatment decisions.

FDA Grants Fast Track to UB-VV111 for B-Cell Blood Cancers

October 8th 2025, 3:04pm

The FDA granted fast track status to UB-VV111 for patients with relapsed or refractory large B-cell lymphoma or chronic lymphocytic leukemia.

I No Longer Think About Cancer Every Day

September 30th 2025, 5:00pm